Company Monitoring Page for MannKind

latest headlines for company on cafepharma

MannKind: Marketing glitches, delays explain slow Afrezza uptake
BioPharma Dive
Wed, 05/13/15 - 11:27 am
Tags:
MannKind, Sanofi, diabetes, Afrezza, inhaled insulin
Analysts 'skeptical' Sanofi can turn around Afrezza launch, but DTC ads are coming
Fierce Pharma
Tue, 05/12/15 - 04:19 pm
Tags:
Afrezza, Sanofi, drug launches, inhaled insulin, diabetes, MannKind
MannKind: ‘Early Launch Struggles Could Be Difficult to Overcome’
Barron's
Tue, 05/12/15 - 08:13 am
Tags:
MannKind, drug launches, diabetes, Afrezza, Sanofi
Five Reasons MannKind's Q1 Performance Rang Loud Alarm Bells
TheStreet.com
Fri, 05/8/15 - 12:11 pm
Tags:
MannKind, earnings
Afrezza Users Calling For MannKind To Produce A 2 Unit Cartridge
Seeking Alpha
Wed, 05/6/15 - 02:08 pm
Tags:
MannKind, diabetes, insulin, Afrezza, inhaled insulin
Afrezza Officially 'Unofficially' Hits $1 Million In Sales
Seeking Alpha
Tue, 05/5/15 - 08:41 am
Tags:
Afrezza, diabetes, MannKind, Sanofi, insulin, inhaled insulin
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
TheStreet.com
Wed, 04/29/15 - 06:50 pm
Tags:
MannKind, Afrezza, diabetes, Sanofi, earnings
MannKind to Manufacture 12 Unit Cartridge Strength of AFREZZA(R) Following FDA Approval
Yahoo
Mon, 04/27/15 - 10:00 am
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
What's Afrezza's Ultimate Potential For MannKind?
Yahoo/Benzinga
Thu, 04/16/15 - 02:03 pm
Tags:
Afrezza, diabetes, MannKind, inhaled insulin
Analyst: MannKind Afrezza Estimates Are Being Changed 'Based On Physician Feedback'
Yahoo/Benzinga
Wed, 03/25/15 - 08:46 am
Tags:
MannKind, Afrezza, diabetes, physicians
MannKind: More Confidence, Lower Target
Barron's
Tue, 03/24/15 - 10:34 am
Tags:
MannKind, diabetes, inhaled insulin
MannKind's Financial Health Complicated by Looming $100M Debt Payment
TheStreet.com
Wed, 03/18/15 - 11:01 am
Tags:
MannKind
A Look At Afrezza Prescriptions Through Week 6 And Predictions Through Week 10
Seeking Alpha
Mon, 03/16/15 - 10:53 am
Tags:
Afrezza, MannKind, Sanofi, insulin, diabetes
If You 'Want To Make A Good Drug Great' Cost Must Be Factored In
Forbes
Tue, 03/3/15 - 09:54 am
Tags:
drug pricing, Afrezza, MannKind, Sanofi, inhaled insulin
Is This The Year That MannKind Turns It Around?
Investopedia
Tue, 03/3/15 - 07:53 am
Tags:
MannKind, Afrezza, diabetes
MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
TheStreet.com
Mon, 03/2/15 - 09:11 am
Tags:
MannKind, Afrezza, insulin, diabetes, Sanofi
MannKind Is Tripling Production To Meet Future Demand
Seeking Alpha
Wed, 02/25/15 - 04:23 pm
Tags:
MannKind, Afrezza, diabetes
Meet MannKind Corporation's New Boss (No, the Other One)
Motley Fool
Tue, 02/24/15 - 09:38 am
Tags:
MannKind, Sanofi, Olivier Brandicourt
Afrezza Will Succeed But Initial Sales Likely To Disappoint
Forbes
Fri, 02/20/15 - 11:00 am
Tags:
Afrezza, diabetes, MannKind, inhaled insulin
No MannKind Buyout Until Afrezza Is Profitable
Seeking Alpha
Wed, 02/18/15 - 08:43 am
Tags:
MannKind, M&A, Afrezza, insulin, diabetes, inhaled insulin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.